Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

NICE launched a new 5-year strategy for 2021-2026

On April 19, 2021, NICE presented a new 5-year strategic plan at the virtual event. NICE provided clarifications and answered the questions on its strategy for 2021-2026, published in April.

Four pillars were identified to enable the NICE 5-year strategy. They represent the areas where NICE has the most significant impact. NICE will progress delivery of these alongside "business as usual."

  • Pillar 1 "Rapid, robust, and responsive technology evaluation;"
  • Pillar 2 "Dynamic, living guideline recommendations;"
  • Pillar 3 "Effective guidance uptake to maximize the NICE impact;"
  • Pillar 4 "Leadership in data, research, and science."

Among many other things, the following plans were announced:

  • To increase NICE' role as an enabler of market access for innovative technologies;
  • To develop robust and responsive methods and processes for the rapid evaluation of new and emerging products, including diagnostics, Medtech, digital health, genomics, and "hybrid" technologies, and increase the proportion of these technologies' assessments;
  • To move from producing full guidelines to a more modular, living approach of recommendations or clusters of recommendations, enabling rapid updates and a more efficient process. NICE will develop selected guidelines in a new interactive format in 2021/22;
  • To focus on collaboration, including earlier engagement with the industry while developing guidelines. The launch of the beta version of the new life sciences hub is scheduled for 2021/22;
  • To launch new Office for Digital Health that scheduled for 2021/22.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).